In-Licensing and Product Acquisitions
A dedicated and flexible partner, Ariston provides the development capabilities, the financial resources and the driven expertise of a small internal team and a comprehensive external team to bring products to market quickly and efficiently.
Ariston is immediately seeking additional products that provide a strategic fit with its current portfolio. Clinical stage and late pre-clinical stage products in the following areas are of particular interest:
- neurology
- pain
Out-Licensing and Co-Commercialization
Ariston seeks to out-license rights outside the US market, typically after Phase II.
Ariston will seek out-licensing or commercialization alliances in the US when appropriate to augment Ariston's planned specialty sales force.
- Ariston expects the lead product for migraine prevention to be ready for out-licensing in 2008
Contact Ariston Business Development
Malcolm Morville, PhD
President & CEO
mmorville@aristonpharma.com
508.665.4260 ext 113